Skip to content
2000
Volume 20, Issue 10
  • ISSN: 1566-5240
  • E-ISSN: 1875-5666

Abstract

Adeno-associated virus (AAV) is one of the most promising viral gene delivery vectors with long-term gene expression and disease correction, featuring high efficiency and excellent safety in human clinical trials. During the production of AAV vectors, there are several quality control (QC) parameters that should be rigorously monitored to comply with clinical safety and efficacy. This review gives a short summary of the most frequently used AVV production and purification methods, focusing on the analytical techniques applied to determine the full/empty capsid ratio and the integrity of the encapsidated therapeutic DNA of the products.

Loading

Article metrics loading...

/content/journals/cmm/10.2174/1566524020999200730181042
2020-12-01
2025-10-16
Loading full text...

Full text loading...

/content/journals/cmm/10.2174/1566524020999200730181042
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test